What the Supreme Court Is Really Testing in Sky Marketing

The Texas Supreme Court’s hearing in Texas Department of State Health Services v. Sky Marketing had the calm, deliberate feel of a court doing what courts are supposed to do: strip away the noise, ignore the moral-panic political theatrics across the plaza in the east wing of the Capitol, and read the statute because that’s what matters. The case arrives dressed in administrative-law vocabulary—standing, sovereign immunity, ultra vires, temporary injunction mechanics—but everyone in the room understood the real stakes. Texas legalized hemp in 2019, a regulated market formed in reliance on that law, and then an agency announced a reinterpretation that snapped the market’s spine. The question now is whether that kind of regulatory whiplash can be insulated from judicial review by calling it a “clarification.”

I’ve watched this dispute evolve since the beginning, from district court record-building to today’s argument. That history matters because what looks like a narrow legal fight from a distance is, up close, a case about institutional limits and whether agencies may do by administrative maneuver what the Legislature would not—or could not—do by statute. And this case potentially sets the stage for a challenge to the latest iteration of government by gaslight—the DSHS proposed permanent hemp rules (see previous article.)

The justices’ questions signaled an important choice point. They were not there to referee policy preferences about delta-8, hemp-derived intoxicants, or the cultural anxieties legislators like to launder through “for the children” messaging. They were there to test the boundaries of delegated authority, the coherence of the State’s standing theory, and the legitimacy of using regulatory communication as a substitute for formal rulemaking.

 

---

 

 

The State’s Framing: “Longstanding Efforts” and a “Clarification”

 

Arguing for the State, Ryan Scanlon, in his capacity as Assistant Solicitor General, opened with a familiar frame: Texas has long tried to control THC, “the high-inducing substance naturally found in the cannabis plant,” and Texas’s hemp program was never meant to be “a legally permissible vehicle for the proliferation of synthetic and intoxicating forms of that drug.”

That opening is not accidental. It tries to position the case as a continuity story—Texas doing what Texas has always done—so that the agency’s 2021 action reads as inevitable maintenance rather than a material shift. Scanlon pushed that theme hard. On the merits, he argued the Commissioner did not “place delta-8 on the schedule,” because delta-8 is simply “a form of THC,” and “THC has always been on the schedule.” What happened, he insisted, was “a clarification.”

The legal strategy underneath that word choice is obvious. If it was only a clarification, then the case starts to look like an attempt to litigate policy through injunctive relief, rather than a challenge to an agency action that exceeded statutory authority. If it was only a clarification, the State wants the Court to treat the economic disruption as either irrelevant or not fairly traceable to the Commissioner’s action. If it was only a clarification, the injunction looks like an improper universal freeze of “the effectiveness of the amendments,” instead of a conventional restraint on unlawful enforcement.

The justices did not accept that premise as a given. They treated “clarification” as a claim that must survive contact with consequences.

 

---

 

 

Standing: The State’s Escape Hatch Meets the Real World

Scanlon leaned heavily on standing and sovereign immunity. His core point was that the Commissioner sets the schedules but does not enforce the criminal law. Without criminal enforcement authority, the State argued, challengers cannot establish standing to sue this official, and sovereign immunity bars the suit.

The Court immediately started probing the reality behind that doctrinal posture. One justice asked the basic question any regulated business would ask: if a party may be prosecuted for violating the rule, does it matter who initiates it? Scanlon answered that it does matter, invoking this Court’s 2020 reasoning in Abbott—if the official you sued cannot bring a criminal prosecution, you may lack standing.

 

That line of argument has a certain internal elegance, but it runs into the way regulation actually works in Texas. Modern regulatory harm does not wait politely for an indictment. It arrives through licensing consequences, market signals, official statements, and the chilling effect of uncertainty.

Justice Rebeca Huddle went straight to that point. “What about the civil side?” she asked. “Don’t they have authority to revoke a license, issue monetary penalties? What about them?”

 

Scanlon conceded there is civil authority, but then tried to escape it: those allegations, he said, were not pleaded, and in any event the civil licensing scheme “has nothing to do with the Controlled Substances Act.”

That answer prompted something close to the central standing issue in this case: if the Commissioner’s scheduling decision changes what products are treated as lawful, how can the State insist there is no traceable injury to regulated businesses? Justice Crosby pressed that logic, noting the respondents’ evidence that they lost money because they could no longer market certain products. Scanlon’s response was essentially that licensing only applies once the product is already a legal hemp product—and therefore scheduling cannot be the cause of their injury.

The bench treated that as a merits question wearing a standing costume. If the whole fight is whether the Commissioner’s action reclassified what counts as a legal hemp product, then saying “licensing only applies to legal hemp products” just restates the dispute. You can’t resolve standing by assuming your own conclusion.

A separate justice sharpened it further: the Court recognizes “standing for a pocketbook injury,” and if businesses are “losing money because of something your client did,” why isn’t that enough? Scanlon tried to cabin pocketbook standing to rate cases and reimbursement settings where the agency action directly sets a number. He argued this case lacks that directness.

That answer did not appear to satisfy the bench’s concern, because the Court kept returning to consequence: the economic disruption was not hypothetical; it was immediate; and it tracked the agency’s public posture. When Scanlon was asked whether the Commissioner had “threatened enforcement,” he responded bluntly: “The Commissioner has not threatened enforcement.”

That is where the State’s standing theory begins to look like an attempt to convert regulatory power into accountability-free power. If an agency can announce a new interpretation that chills the market, triggers compliance retreat, and collapses investment, and then claim there is no standing because it did not personally make an arrest, the Court is left endorsing a model of governance where the most economically destructive tools are the least reviewable.

The justices’ questions suggested they understand that trap.

 

---

 

 

The Court Tests the “Clarification” Story

The most important pressure the Court applied today was conceptual. The justices kept returning to the mismatch between the State’s description of its action and the industry’s lived reality.

Justice Bland asked one of the most consequential questions: what is the State’s best argument that treating delta-8 as controlled does not conflict with the definition of hemp in the Texas farm bill?

 

Scanlon’s response was to double down: delta-8 wasn’t “placed” on the schedule; it is THC; THC was always scheduled; the Commissioner merely clarified after federal changes.

 

Then came the chemistry and process discussion. Bland asked whether delta-8 is derived or extracted from the cannabis plant. Scanlon answered with a layered explanation: not directly from hemp, he suggested, but from CBD extracted from hemp, with a synthesis process described by CDC and FDA. In other words, delta-8 in commercial form is typically manufactured through chemical conversion rather than extracted as-is at scale.

Scanlon leaned on the DEA observation that in a natural hemp plant under the delta-9 threshold, delta-8 appears only in trace amounts; therefore, when Texas law talks about THCs in hemp, it is talking about naturally occurring trace presence, not manufactured potency.

That framing is politically useful—“trace amounts good, manufactured intoxicants bad”—but it has a legal problem: the Legislature wrote a definition that includes derivatives and isomers and drew the line at delta-9 concentration. If the Legislature intended to prohibit conversion manufacturing or to outlaw certain isomers regardless of delta-9, it had ample opportunity to say so. The State is now asking the Court to infer a narrower legislative intent from federal agency commentary and chemical process descriptions.

That is precisely the sort of move Texas courts scrutinize when assessing ultra vires conduct.

 

---

 

 

Taylor’s Presentation: Calm, Clear, and Commanding

When Amanda Taylor rose for Sky Marketing, the tonal shift in the courtroom was immediate. Some advocates respond to questions as if they’re being interrupted. Taylor responded as if the justices were doing her a favor by letting her show her work. She framed the case where it belongs: “the bounds of the agency authority expressly delegated by our Legislature.” Policy debates about hemp might be “interesting or controversial,” she said, but the Court’s job is to say what the law means and apply it.

That opening did two things at once. It reduced the State’s moralizing posture to background noise, and it invited the justices to act like judges rather than referees in a culture fight.

Justice Bland asked the key threshold question: is the Commissioner’s decision subject to judicial review? Taylor answered without flinching: yes. Then she did what excellent appellate lawyers do: she took the State’s statutory hook—subsection G—and narrowed it to its actual scope. Subsection G, she explained, addresses the decision whether to conform with federal scheduling changes; it does not authorize the Commissioner to “unilaterally modify the schedule and make it inconsistent with existing Texas law.”

Taylor’s most effective moment came when she confronted the “clarification” label. If the State truly believes no legally significant change occurred, why is the action ultra vires? Taylor’s answer was crisp and procedural: subsection G permits only one type of change—conform or decline. Any “alteration other than the federal conformance change” must proceed under subsection B, which requires notice and hearing on the modification itself, not merely on an objection.

Then she layered in the additional statutory failures: missing findings, failure to notify other agencies with overlapping authority within ten days, and lack of required approval by the Executive Commissioner of HHSC. “None of that occurred.”

Her delivery was exactly what you want when you’re asking a court to enforce limits on agency power: clear, smooth, unruffled, and relentlessly grounded in the statutory roadmap. She sounded like someone who had read the whole record, not just the parts that make her point.

 

---

 

 

The Legislature’s Hemp Line: Delta-9 as the Bright Line

 

Taylor also anchored the case in the 2019 hemp framework in a way that forced the Court to confront the Legislature’s design. The statute, she argued, says hemp and THC in hemp are not controlled substances, with legality limited by delta-9: above 0.3% delta-9 is marijuana; below is hemp and not controlled.

That matters because the State’s position tries to smuggle in a different legality test: not the delta-9 threshold, but a broader concept of “THC isomers and analogs” depending on origin or manufacturing method. Once you move away from the statute’s bright line and toward agency-driven categorization, you effectively rewrite the Legislature’s compromise.

Justice Young pressed on delegation—this is an area where the Legislature delegates heavily, so why do we need the statutory limits Taylor was invoking? Taylor’s response was grounded in the 2019 statute’s explicitness: the definition includes derivatives and isomers, and it defines processing and manufacturing in a way that contemplates a regulated consumable market, including conversion and manufacturing.

She also addressed the State’s “synthetics” obsession with a controlled burn. “This lawsuit is not about synthetics,” she said. The State used that word “throughout the State’s brief,” but Sky Marketing did not seek relief tied to that language. This case was brought by businesses and consumers producing and using “legal consumable products made from naturally derived substances.”

That was not mere positioning. It was a strategic narrowing designed to keep the Court from being pulled into a broader political fight the State would prefer to litigate in moral terms.

 

---

 

 

 

 

 

The Injunction and the Court’s Discomfort with a Universal Freeze

 

Another line of questioning the Court pressed with particular care concerned the form of the temporary injunction itself. One justice focused on whether the order had slipped from party-specific relief into something broader, noting that it appeared to restrain the “effectiveness of the amendments,” rather than simply prohibiting their enforcement against the plaintiffs. Framed that way, the concern was not semantic but structural: whether the injunction operated in rem rather than in personam.

Taylor met the question head-on. The injunction, she explained, was prospective relief designed to prevent ongoing harm while the merits are litigated, not a judicial repeal of the statute or rules. The language may have been broad, but its function was conventional: to restrain unlawful enforcement of an ultra vires action pending judicial review. She pointed the Court to precedent recognizing that courts routinely prevent continued harm from invalid agency action without purporting to legislate for nonparties.

The State countered that the injunction crossed a constitutional line. By enjoining the “effectiveness” of the scheduling amendments, it argued, the trial court had issued relief that functioned universally, not merely against the named defendants. That, in the State’s telling, transformed a routine injunction into a policy freeze—precisely the sort of relief Texas courts have grown wary of in recent years.

What made the exchange consequential was not the labels, but the Court’s evident concern with how injunctions operate in practice. Texas courts have repeatedly cautioned against orders that look less like dispute resolution and more like administrative suspension. The justices’ questions reflected that unease.

In rebuttal, Scanlon appeared less prepared on this ground. He acknowledged that he had not fully briefed the universal-injunction issue and asked for the opportunity to address it later. That moment lingered, because it reinforced a pattern already visible in the argument: a reliance on formal categorization where the Court was probing functional effect.

The critique of the State’s presentation crystallized there. Scanlon’s advocacy was confident and technically fluent, but it repeatedly assumed that doctrinal labels—“clarification,” “no enforcement authority,” “separate licensing scheme”—were sufficient answers, even when they failed to account for what actually happened to the regulated community. As the bench pressed on scope and consequence, the answers drifted toward procedural abstraction.

Taylor, by contrast, made the Court’s work easier. She offered clean handles rather than evasions: a statute with a clear roadmap, identifiable procedural failures, and a theory of harm that aligned with how regulation actually operates in the real world. That difference in approach mattered, because the Court was plainly less interested in how the injunction was described than in whether it functioned as a proper exercise of equity.The Hearing’s Quiet Theme: Consequences Count

Perhaps the most telling aspect of the argument was how frequently the justices returned to consequences—economic injury, compliance whiplash, and the real-world effects of regulatory signaling. The State tried to confine the case to the absence of criminal enforcement and the formal separateness of licensing from scheduling. The bench kept tugging back toward what happens when an agency speaks and the market believes it must obey.

Taylor captured the point in her standing discussion, emphasizing that the agency’s website statement operates as a threat and that the State has not disclaimed intent to enforce.  The record, she noted, showed “immediate economic disruption” once the policy was announced: businesses stopped selling products; reputations were harmed; layoffs were considered.

When the Chief Justice closed the argument, the case was submitted with the sense that the Court had identified the case’s true center of gravity: not whether delta-8 is controversial, but whether the law permits an agency to accomplish a substantive change under the banner of refusing a federal change, without following the statutory procedure for changing Texas law.

 

---

 

Why This Case Matters to the Structure of Texas Government

Texas has lived for years inside a mismatch: the Legislature wrote a definition and a bright line in 2019, the market organized itself around that line, and then agencies and political actors tried to claw back ground through reinterpretation and enforcement posture. That conflict will not end until either the Legislature redraws the statute clearly or the courts enforce the boundaries of delegation.

If the State’s theory prevails, agencies gain a path to reshape statutory meaning through public posture and interpretive maneuvers, insulated by standing doctrine so long as they avoid being the official who files charges. That model expands administrative power while shrinking accountability.

If Sky Marketing’s theory prevails, the Court reaffirms something Texas needs right now: delegated authority has limits, and those limits still bind even when politics gets impatient.

Amanda Taylor argued that position with clarity, smoothness, and a calm command of the record and the law that never wavered. Ryan Scanlon, serving as Assistant Solicitor General, offered a theory that was formally neat but repeatedly struggled to match consequence with characterization. The justices noticed. They pressed. They circled back. They kept asking the same question from different angles until the contradiction could no longer hide behind labels.

Let’s hope that kind of judicial rigor still counts where it matters.

 

---

 

 

Author

The author was an initial plaintiff and later a witness in this case at the district court level and assisted in recruiting some of the plaintiffs and counsel. At the time, he served as Executive Director of the Texas Hemp Federation and worked closely with the former leadership of Hometown Hero, whose parent company, Sky Marketing, is the named respondent here.

That perspective is offered not to personalize the outcome, but to explain why the Court’s questions resonated so strongly. The author has seen, under oath and in real time, how regulatory ambiguity is created and how quickly it can destabilize manufacturers, distributors and wholesalers, and retailers operating in good faith. The issues before the Supreme Court today are the same ones the trial court confronted years ago, and they remain the right ones.